Status:
COMPLETED
Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea
Lead Sponsor:
Medical College of Wisconsin
Collaborating Sponsors:
ResMed
Conditions:
Sleep Apnea
Sleep Disordered Breathing
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Patients with Obstructive Sleep Apnea Syndrome (OSAS) will evidence higher levels of salivary cortisol and alpha-amylase levels prior to use of placebo and continuous positive airway pressure (CPAP) a...
Detailed Description
It has been shown that there is an inconsistent response in serum cortisol levels in patients with Obstructive Sleep Apnea Syndrome (OSAS), but it is undetermined whether a change in hormone level was...
Eligibility Criteria
Inclusion
- Adults
- Male and female
- Between ages 18 and 90
- Undergo a Polysomnography (PSG) with evidence of any sleep disordered breathing including snoring, mild/moderate/severe sleep apnea, and/or restless legs
Exclusion
- Ages 17 and under
- Pregnant women
Key Trial Info
Start Date :
November 15 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2011
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01196117
Start Date
November 15 2004
End Date
December 15 2011
Last Update
April 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Froedtert West Clinics - Otolaryngology Clinc
Milwaukee, Wisconsin, United States, 53226